eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/01/2012
PIL Fendrix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 03/09/2010 and displayed until 11/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Changes to therapeutic indications
Updated on 06/05/2010 and displayed until 03/09/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 14/12/2009 and displayed until 06/05/2010
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 18/03/2009 and displayed until 14/12/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 28/06/2006 and displayed until 18/03/2009
Reasons for adding or updating:
  • Change to Further Information section
Updated on 29/09/2005 and displayed until 28/06/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  hepatitis b antigen